A lawsuit over a requirement that women prescribed a two-drug regimen to induce an abortion get one of the pills at a doctor’s office, hospital, or medical clinic is over, as a federal court dismissed it Thursday.
The U.S. District Court for the District of Maryland acted on a notice of voluntary dismissal filed by women’s medical providers that had challenged the in-person delivery rule for mifepristone.
The drug is used during the earliest stage of pregnancy and must be prescribed by licensed medical providers. It is self-administered by women, usually outside of a clinical setting.
The American College of ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.